Stay updated with breaking news from Anteri Com. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The flagship transcatheter heart valve of Anteris Technologies Ltd (ASX:AVR, OTC:AMEUF) has been successfully implanted during a valve-in-valve procedure as...
BRISBANE, Australia & MINNEAPOLIS, July 31, 2023--Anteris Technologies Ltd, (Anteris or the Company) (ASX: AVR), a structural heart company developing DurAVR™ THV, a new class of biomimetic heart valve and the world’s only balloon-expandable, single-piece transcatheter aortic valve shaped to mimic the performance of a native human aortic valve, announces that the DurAVR™ THV was used for the first time in a valve-in-valve (ViV) procedure as part of Health Canada’s Special Access Program (SAP).